{"id":"https://openalex.org/W2059997671","doi":"https://doi.org/10.1159/000215133","title":"Evidence of Fibrinogen Breakdown by Leukocyte Enzymes in a Patient with Acute Promyelocytic Leukemia","display_name":"Evidence of Fibrinogen Breakdown by Leukocyte Enzymes in a Patient with Acute Promyelocytic Leukemia","publication_year":2009,"publication_date":"2009-04-21","ids":{"openalex":"https://openalex.org/W2059997671","doi":"https://doi.org/10.1159/000215133","mag":"2059997671","pmid":"https://pubmed.ncbi.nlm.nih.gov/3859461"},"language":"en","primary_location":{"id":"doi:10.1159/000215133","doi":"https://doi.org/10.1159/000215133","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000215133","pdf_url":null,"source":{"id":"https://openalex.org/S25130563","display_name":"Haemostasis","issn_l":"0301-0147","issn":["0301-0147","1423-0038"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemostasis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005138677","display_name":"Lydi Sterrenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148297040","display_name":"Netherlands Organisation for Applied Scientific Research","ror":"https://ror.org/01bnjb948","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I148297040"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Lydi Sterrenberg","raw_affiliation_strings":["Gaubius Institute, Health Research Division TNO, Leiden, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gaubius Institute, Health Research Division TNO, Leiden, and","institution_ids":["https://openalex.org/I148297040"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047459192","display_name":"Hans L. Haak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans L. Haak","raw_affiliation_strings":["Leyenburg Hospital, Department of Hematology, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leyenburg Hospital, Department of Hematology, The Hague, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025934686","display_name":"Emile J.P. Brommer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148297040","display_name":"Netherlands Organisation for Applied Scientific Research","ror":"https://ror.org/01bnjb948","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I148297040"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Emile J.P. Brommer","raw_affiliation_strings":["Gaubius Institute, Health Research Division TNO, Leiden, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gaubius Institute, Health Research Division TNO, Leiden, and","institution_ids":["https://openalex.org/I148297040"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108526690","display_name":"W. Nieuwenhuizen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148297040","display_name":"Netherlands Organisation for Applied Scientific Research","ror":"https://ror.org/01bnjb948","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I148297040"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Willem Nieuwenhuizen","raw_affiliation_strings":["Gaubius Institute, Health Research Division TNO, Leiden, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gaubius Institute, Health Research Division TNO, Leiden, and","institution_ids":["https://openalex.org/I148297040"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3083,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.82493096,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"15","issue":"2","first_page":"126","last_page":"133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11721","display_name":"Blood properties and coagulation","score":0.8148999810218811,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11721","display_name":"Blood properties and coagulation","score":0.8148999810218811,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.17980000376701355,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibrinogen-degradation","display_name":"fibrinogen degradation","score":0.9129999876022339},{"id":"https://openalex.org/keywords/leukocyte-elastase","display_name":"leukocyte elastase","score":0.9440000057220459},{"id":"https://openalex.org/keywords/acute-promyelocytic-leukemia","display_name":"acute promyelocytic leukemia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9309999942779541},{"id":"https://openalex.org/keywords/fibrinogen-degradation-products","display_name":"fibrinogen degradation products","score":0.8059999942779541},{"id":"https://openalex.org/keywords/anticoagulant-activity","display_name":"anticoagulant activity","score":0.9330000281333923},{"id":"https://openalex.org/keywords/thrombin-time","display_name":"thrombin time","score":0.824999988079071},{"id":"https://openalex.org/keywords/alpha2-antiplasmin","display_name":"alpha2-antiplasmin","score":0.8629999756813049},{"id":"https://openalex.org/keywords/plasminogen","display_name":"plasminogen","score":0.9819999933242798},{"id":"https://openalex.org/keywords/antithrombin-iii","display_name":"antithrombin III","score":0.9980000257492065},{"id":"https://openalex.org/keywords/enzyme-release","display_name":"enzyme release","score":0.4269999861717224},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.9081218242645264},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6131831407546997},{"id":"https://openalex.org/C2779026020","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombin","level":3,"score":0.6061362624168396},{"id":"https://openalex.org/C2776601000","wikidata":"https://www.wikidata.org/wiki/Q612108","display_name":"Acute promyelocytic leukemia","level":4,"score":0.591253399848938},{"id":"https://openalex.org/C2781044401","wikidata":"https://www.wikidata.org/wiki/Q418897","display_name":"Elastase","level":3,"score":0.5347745418548584},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.5182385444641113},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.4405978322029114},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4252520799636841},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4071478545665741},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3709592819213867},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.3620120882987976},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.355325847864151},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3525937795639038},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33327561616897583},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3201870322227478},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.16766923666000366},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000990","descriptor_name":"Antithrombin III","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D001778","descriptor_name":"Blood Coagulation Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001778","descriptor_name":"Blood Coagulation Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003937","descriptor_name":"Diagnosis, Differential","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004211","descriptor_name":"Disseminated Intravascular Coagulation","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005338","descriptor_name":"Fibrin Fibrinogen Degradation Products","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006098","descriptor_name":"Granulocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006098","descriptor_name":"Granulocytes","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010196","descriptor_name":"Pancreatic Elastase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D013918","descriptor_name":"Thrombin Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000215133","doi":"https://doi.org/10.1159/000215133","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000215133","pdf_url":null,"source":{"id":"https://openalex.org/S25130563","display_name":"Haemostasis","issn_l":"0301-0147","issn":["0301-0147","1423-0038"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemostasis","raw_type":"journal-article"},{"id":"pmid:3859461","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3859461","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemostasis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2200212076","https://openalex.org/W1970011970","https://openalex.org/W2396374730","https://openalex.org/W2049281744","https://openalex.org/W2474406881","https://openalex.org/W2436550095","https://openalex.org/W2945154199","https://openalex.org/W2155970808","https://openalex.org/W2066371116","https://openalex.org/W2360335329"],"abstract_inverted_index":{"On":[0],"daunomycin":[1],"treatment":[2],"of":[3,75,99,106,118,137],"a":[4,43,48,63,78],"patient":[5],"with":[6,57],"promyelocytic":[7],"leukemia,":[8],"leukocyte":[9,58],"elastase":[10,59,107],"appeared":[11],"in":[12,15,47,60,109,139],"large":[13,79],"amounts":[14],"the":[16,20,100,104,110,115,130],"patient's":[17],"blood.":[18],"Also,":[19],"plasma":[21],"fibrinogen":[22,32,37,53,76,102,138],"was":[23,127],"found":[24],"to":[25,29,77],"be":[26],"partially":[27],"degraded":[28],"early,":[30],"X-like,":[31],"degradation":[33,54,71,136],"products.":[34],"These":[35],"early":[36],"fragments":[38],"were":[39,87,92,133],"isolated":[40,101],"and":[41,84,113],"showed":[42],"low":[44,65,96],"anticoagulant":[45,66,97],"activity":[46,98,108],"thrombin":[49],"time":[50],"test.":[51],"Early":[52],"products,":[55],"produced":[56],"vitro,":[61],"have":[62],"similar":[64],"activity.":[67],"In":[68],"contrast,":[69],"plasmic":[70],"products":[72],"inhibit":[73],"clotting":[74],"extent.":[80],"Although":[81],"alpha":[82],"2-antiplasmin":[83],"plasminogen":[85],"levels":[86,91,117],"low,":[88],"antithrombin":[89,119],"III":[90,120],"not":[93],"decreased.":[94],"The":[95],"fragments,":[103],"presence":[105],"plasma--both":[111],"immunological":[112],"amidolytic--and":[114],"normal":[116],"suggest":[121],"that":[122],"granulocytic":[123],"enzymes,":[124],"whose":[125],"release":[126],"enhanced":[128],"by":[129],"cytostatic":[131],"treatment,":[132],"responsible":[134],"for":[135],"this":[140],"patient.":[141]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}